Delivery Order SPE2DB20D2104-SPE2DB23FT62X
- Not listed
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a delivery order contract worth $1,326.52 to provide 4565108064 Plaquenil 200 mg Tablets in 100-count packages. This contract is a firm-fixed price arrangement with a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, was selected for this award without any set-aside designation, highlighting its competitive position in the federal medical supply...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,026.35, is for the delivery of Plaquenil 200 mg tablets over the period ending November 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide PLAQUENIL 200 MG TABLET 100S. The award has a ceiling value of $2,191.75 and is a Firm Fixed Price Delivery Order contract that runs through April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
- This is a delivery order worth $1,700.65 awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) on March 6, 2023. The contract is for the delivery of Plaquenil 200 mg tablets in 100-count containers, with a completion date of March 7, 2023. The contract is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.92 firm fixed-price delivery order is for the supply of 4,566,077,675 units of hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of October 11, 2024. This award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at three thousand seven hundred eighty-five dollars and eighty-four cents ($3,785.84) to Amerisourcebergen Drug Corporation for the provision of two hundred (200) tablets of Plaquenil, a malaria drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with work scheduled to be completed by July 20, 2023 under the contract start date of July 19, 2023. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of chloroquine phosphate 500 mg tablets. The $27,583.44 firm fixed price delivery order contract has a completion date of June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
- <p>The Defense Logistics Agency issued a $2,342.91 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Plaquemin 200 mg tablets (100-count units), with ultimate completion on March 6, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- This federal contract award, with the ID SPE2DB20D3103|SPE2DB24FL8W1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,080 units of hydroxychloroquine 200 mg tablets, with a ceiling value of $3,572.70 and a completion date of December 13, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Hydroxychloroquine 200 mg, with a contract value of $2,780.34 and a firm fixed price structure. This non-competitive delivery order, issued on December 12, 2025, is due for completion by December 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement from the company's existing Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT62XDelivery Order
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,922.65 for the supply of Plaquenil 200 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 23, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 5/22/23 |